{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:24:39Z","timestamp":1768267479907,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:00:00Z","timestamp":1707004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ad.2023.10.045","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T08:53:43Z","timestamp":1707296023000},"page":"T368-T373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["[Translated article] Actinic Keratosis in Solid Organ Transplant Recipients: A Medical Literature Review"],"prefix":"10.1016","volume":"115","author":[{"given":"A.","family":"Morell\u00f3 Vicente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Oteiza Rius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Aguado Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2023.10.045_bib0240","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjd.15950","article-title":"Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"177","author":"Blomberg","year":"2017","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.045_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-09722-8","article-title":"Spontaneous regression rates of actinic keratosis: A systematic review and pooled analysis of randomized controlled trials","volume":"12","author":"Steeb","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ad.2023.10.045_bib0250","first-page":"s161","article-title":"Actinic Keratosis: Current Therapies and Insights Into New Treatments","volume":"18","author":"Hashim","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2023.10.045_bib0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2340\/00015555-2783","article-title":"Incidence and regression of actinic keratoses in organ transplant recipients","volume":"98","author":"Jiyad","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2023.10.045_bib0260","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: A systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.10.045_bib0265","doi-asserted-by":"crossref","first-page":"335","DOI":"10.36849\/JDD.2020.4759","article-title":"Field therapy in solid organ transplant recipients: Are we initiating early enough?","volume":"19","author":"Topham","year":"2020","journal-title":"J Drugs Dermatology"},{"key":"10.1016\/j.ad.2023.10.045_bib0270","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000529369","article-title":"Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study","volume":"239","author":"Wenande","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2023.10.045_bib0275","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jamadermatol.2021.4148","article-title":"Risks of Multiple Skin Cancers in Organ Transplant Recipients: A Cohort Study in 2 Administrative Data Sets","volume":"157","author":"Wehner","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2023.10.045_bib0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2340\/00015555-3498","article-title":"Update on the management of cutaneous squamous cell carcinoma","volume":"100","author":"Maubec","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2023.10.045_bib0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bjd.17148","article-title":"Local interventions for actinic keratosis in organ transplant recipients: a systematic review","volume":"180","author":"Heppt","year":"2019","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.045_bib0290","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1468-3083.2011.04356.x","article-title":"Photodynamic therapy for actinic keratosis in organ transplant patients","volume":"27","author":"Basset-Seguin","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.10.045_bib0295","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00015550510042868","article-title":"Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients","volume":"86","author":"Wulf","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2023.10.045_bib0300","first-page":"1099","article-title":"Treatment of actinic keratosis: a systematic review","volume":"315","author":"Worley","year":"2023","journal-title":"Arch Dermatol Res."},{"key":"10.1016\/j.ad.2023.10.045_bib0305","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/bjd.12343","article-title":"Network meta-analysis of the outcome \u201cparticipant complete clearance\u201d in nonimmunosuppressed participants of eight interventions for actinic keratosis: A follow-up on a Cochrane review","volume":"169","author":"Gupta","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.10.045_bib0310","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/bjd.15884","article-title":"Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial","volume":"178","author":"Togsverd-Bo","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.045_bib0315","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/jdv.16125","article-title":"Daylight photodynamic therapy for prevention of new actinic keratosis and keratinocyte carcinomas in organ transplants. A cryotherapy-controlled randomized clinical trial","volume":"34","author":"Bernad","year":"2020","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.ad.2023.10.045_bib0320","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2340\/00015555-3274","article-title":"Ablative fractional laser-assisted daylight photodynamic therapy for actinic keratoses of the scalp and forehead in organ transplant recipients: A pilot study","volume":"99","author":"Rizvi","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2023.10.045_bib0325","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bjd.13222","article-title":"Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial","volume":"172","author":"Togsverd-Bo","year":"2015","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.045_bib0330","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archderm.141.8.985","article-title":"Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: Randomized, double-blind, placebo-controlled trial","volume":"141","author":"Brown","year":"2005","journal-title":"Arch Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.ad.2023.10.045_bib0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.08269.x","article-title":"Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients","volume":"157","author":"Ulrich","year":"2007","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.045_bib0340","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2133.2006.07233.x","article-title":"Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases","volume":"155","author":"Ulrich","year":"2006","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.045_bib0345","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjd.20974","article-title":"Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments)","volume":"187","author":"Hasan","year":"2022","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.045_bib0350","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ajd.12158","article-title":"The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses","volume":"55","author":"Ingham","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ad.2023.10.045_bib0355","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","article-title":"Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy","volume":"156","author":"Perrett","year":"2007","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.045_bib0360","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ad.2021.07.006","article-title":"Tirbanibulina: revisi\u00f3n de su mecanismo de acci\u00f3n novedoso y de c\u00f3mo encaja en el tratamiento de la queratosis act\u00ednica","volume":"113","author":"Gilaberte","year":"2022","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2023.10.045_bib0365","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1056\/NEJMoa2024040","article-title":"Phase 3 Tirbanibulin for Actinic Keratosis Group. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis","volume":"384","author":"Blauvelt","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2023.10.045_bib0370","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1684\/ejd.2010.1010","article-title":"Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses","volume":"20","author":"Ulrich","year":"2010","journal-title":"Eur J Dermatology"},{"key":"10.1016\/j.ad.2023.10.045_bib0375","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2023.10.045_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ctr.13736","article-title":"Skin cancer in transplant recipients: Scientific retreat of the international immunosuppression and transplant skin cancer collaborative and skin care in organ transplant patients-Europe","volume":"33","author":"Stevenson","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ad.2023.10.045_bib0385","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","article-title":"Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study","volume":"161 Suppl 3","author":"Ulrich","year":"2009","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2023.10.045_bib0390","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/CCID.S220741","article-title":"Six critical questions for DNA repair enzymes in skincare products: A review in dialog","volume":"12","author":"Yarosh","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.ad.2023.10.045_bib0395","first-page":"480","article-title":"Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients","volume":"12","author":"Alter","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ad.2023.10.045_bib0400","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000001447","article-title":"Cancer and mTOR inhibitors in transplant recipients","volume":"101","author":"De Fijter","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.ad.2023.10.045_bib0405","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.transproceed.2006.08.016","article-title":"Conversion from calcineurin inhibitors to everolimus in kidney transplant recipients with malignant neoplasia","volume":"38","author":"Fern\u00e1ndez","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ad.2023.10.045_bib0410","first-page":"744","article-title":"The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"37","author":"LeBlanc","year":"2011","journal-title":"Dermatologic Surg"},{"key":"10.1016\/j.ad.2023.10.045_bib0415","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaad.2022.02.039","article-title":"Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: A\u00a0randomized, double-blind, placebo-controlled pilot trial","volume":"87","author":"Chong","year":"2022","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2023.10.045_bib0420","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/DSS.0000000000002072","article-title":"Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature","volume":"45","author":"Herold","year":"2019","journal-title":"Dermatologic Surg"},{"key":"10.1016\/j.ad.2023.10.045_bib0425","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2133.2005.06347.x","article-title":"Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: A systematic review of randomized controlled trials","volume":"152","author":"Chen","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.10.045_bib0430","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2023.10.045_bib0435","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.3390\/ijms24054989","article-title":"Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review","volume":"24","author":"Arcuri","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.ad.2023.10.045_bib0440","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jaad.2010.11.063","article-title":"Skin cancer in solid organ transplant recipients: Advances in therapy and management: Part I Epidemiology of skin cancer in solid organ transplant recipients","volume":"65","author":"O\u2019Reilly Zwald","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.10.045_bib0445","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamadermatol.2020.2327","article-title":"Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review","volume":"156","author":"Schauder","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2023.10.045_bib0450","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/dsu.12049","article-title":"Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients","volume":"39","author":"Endrizzi","year":"2013","journal-title":"Dermatologic Surg"},{"key":"10.1016\/j.ad.2023.10.045_bib0455","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1399-0012.2010.01348.x","article-title":"Capecitabine for skin cancer prevention in solid organ transplant recipients","volume":"25","author":"Jirakulaporn","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ad.2023.10.045_bib0460","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/12034754221078201","article-title":"Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis","volume":"26","author":"Mainville","year":"2022","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ad.2023.10.045_bib0465","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2023.10.045_bib0470","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients","volume":"388","author":"Allen","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024000905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024000905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T19:43:26Z","timestamp":1720554206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731024000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0001731024000905"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2023.10.045","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Actinic Keratosis in Solid Organ Transplant Recipients: A Medical Literature Review","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.10.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.10.021","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}